Whalesbook
Shares of Transformers & Rectifiers (India) Limited (TARIL) tumbled 12% on Wednesday, falling to ₹292.90 in intraday trade on the BSE. The sharp decline occurred amidst substantial trading volumes, with nearly double the average number of shares changing hands in the first few minutes of the session across the NSE and BSE.
Q4 Performance Concerns
The market reaction follows the company's reported disappointing performance for the quarter ended March 2026. Although specific Q4 figures were not detailed, the trend of declining profitability was evident in the reported Q3FY26 results. For the third quarter of fiscal year 2026, consolidated profit after tax saw a year-on-year decline of 3.3% to ₹91.1 crore from ₹94.17 crore. Revenue from operations did show robust growth, increasing 15.7% year-on-year to ₹782.67 crore. However, this top-line expansion was overshadowed by a significant contraction in EBITDA margins, which fell 210 basis points to 17.5% from 20.2% a year ago.
Analyst Scrutiny
Brokerage firm ICICI Securities pointed to several critical issues affecting investor sentiment. The firm noted that TARIL's order book stood at ₹5,005 crore as of March 31, 2026, which is significantly below earlier guidance targets of approximately ₹8,000 crore. This shortfall suggests weaker-than-expected order inflows and a cautious approach to booking new orders. Furthermore, ICICI Securities highlighted potential delays in the expansion timelines for the company's Changodar and Moraiya plants. These delays could push back the anticipated growth ramp-up, raising concerns about the company's execution capabilities and the credibility of its FY27 revenue guidance of around ₹3,250 crore.
Management Outlook
Despite these concerns, the management has expressed optimism, attributing revenue improvements to faster execution of major orders, better production planning, and internal controls. They anticipate continued tailwinds, citing infrastructure development initiatives by the government and the 'Viksit Bharat 2047' vision. The company also maintains a healthy tender pipeline exceeding ₹23,000 crore, signaling potential future opportunities.